- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ankylosing spondylitis
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1366KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 104KB)
Ixekizumab – July 2020
Ixekizumab: Injection 80 mg in 1 mL single dose pre-filled pen; Taltz®
Last updated
30 October 2020